Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Respiratory Syncytial Virus—A Comprehensive ReviewClinical reviews in allergy & immunology, 2013-12, Vol.45 (3), p.331-379 [Peer Reviewed Journal]Springer Science+Business Media New York 2013 ;COPYRIGHT 2013 Springer ;ISSN: 1080-0549 ;EISSN: 1559-0267 ;DOI: 10.1007/s12016-013-8368-9 ;PMID: 23575961Full text available |
|
2 |
Material Type: Article
|
The Source of Respiratory Syncytial Virus Infection In Infants: A Household Cohort Study In Rural KenyaThe Journal of infectious diseases, 2014-06, Vol.209 (11), p.1685-1692 [Peer Reviewed Journal]Copyright © 2014 Oxford University Press on behalf of the Infectious Diseases Society of America ;The Author 2013. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. 2013 ;2015 INIST-CNRS ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jit828 ;PMID: 24367040 ;CODEN: JIDIAQFull text available |
|
3 |
Material Type: Article
|
Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older AdultsThe New England journal of medicine, 2023-02, Vol.388 (7), p.595-608 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;COPYRIGHT 2023 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2209604 ;PMID: 36791160Full text available |
|
4 |
Material Type: Article
|
Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in InfantsThe New England journal of medicine, 2023-04, Vol.388 (16), p.1451-1464 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2216480 ;PMID: 37018474Full text available |
|
5 |
Material Type: Article
|
Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in ChildrenThe Journal of infectious diseases, 2020-06, Vol.221 (12), p.2050-2059 [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2020 ;The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jiaa049 ;PMID: 32006006Full text available |
|
6 |
Material Type: Article
|
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older AdultsThe New England journal of medicine, 2023-04, Vol.388 (16), p.1465-1477 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2213836 ;PMID: 37018468Full text available |
|
7 |
Material Type: Article
|
Prefusion F Protein–Based Respiratory Syncytial Virus Immunization in PregnancyThe New England journal of medicine, 2022-04, Vol.386 (17), p.1615-1626 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2106062 ;PMID: 35476650Full text available |
|
8 |
Material Type: Article
|
A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in miceVaccine, 2017-02, Vol.35 (5), p.757-766 [Peer Reviewed Journal]Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Feb 1, 2017 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2016.12.048 ;PMID: 28065474Full text available |
|
9 |
Material Type: Article
|
Respiratory syncytial virus infection in adultsBMJ (Online), 2019-09, Vol.366, p.l5021-l5021 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2019BMJ ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.l5021 ;PMID: 31506273Full text available |
|
10 |
Material Type: Article
|
Respiratory Syncytial Virus Seasonality, Beijing, China, 2007-2015Emerging infectious diseases, 2019-06, Vol.25 (6), p.1127-1135 [Peer Reviewed Journal]COPYRIGHT 2019 U.S. National Center for Infectious Diseases ;COPYRIGHT 2019 U.S. National Center for Infectious Diseases ;ISSN: 1080-6040 ;EISSN: 1080-6059 ;DOI: 10.3201/eid2506.180532 ;PMID: 31107230Full text available |
|
11 |
Material Type: Article
|
The race to make vaccines for a dangerous respiratory virusNature (London), 2021-12, Vol.600 (7889), p.379-380 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-021-03704-y ;PMID: 34893769Full text available |
|
12 |
Material Type: Article
|
Intranasal respiratory syncytial virus vaccine attenuated by codon-pair deoptimization of seven open reading frames is genetically stable and elicits mucosal and systemic immunity and protection against challenge virus replication in hamstersPLoS pathogens, 2024-05, Vol.20 (5), p.e1012198-e1012198 [Peer Reviewed Journal]Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication. ;ISSN: 1553-7366 ;EISSN: 1553-7374 ;DOI: 10.1371/journal.ppat.1012198 ;PMID: 38739647Full text available |
|
13 |
Material Type: Article
|
Protective antigenic sites in respiratory syncytial virus G attachment protein outside the central conserved and cysteine noose domainsPLoS pathogens, 2018-08, Vol.14 (8), p.e1007262-e1007262 [Peer Reviewed Journal]COPYRIGHT 2018 Public Library of Science ;COPYRIGHT 2018 Public Library of Science ;This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication: https://creativecommons.org/publicdomain/zero/1.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1553-7374 ;ISSN: 1553-7366 ;EISSN: 1553-7374 ;DOI: 10.1371/journal.ppat.1007262 ;PMID: 30142227Full text available |
|
14 |
Material Type: Article
|
Neutrophil extracellular traps cause airway obstruction during respiratory syncytial virus diseaseThe Journal of pathology, 2016-02, Vol.238 (3), p.401-411 [Peer Reviewed Journal]Copyright © 2015 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. ;Copyright © 2016 Pathological Society of Great Britain and Ireland ;Wageningen University & Research ;ISSN: 0022-3417 ;EISSN: 1096-9896 ;DOI: 10.1002/path.4660 ;PMID: 26468056Full text available |
|
15 |
Material Type: Article
|
A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton RatsJournal of virology, 2016-08, Vol.90 (16), p.7508-7518 [Peer Reviewed Journal]Copyright © 2016, American Society for Microbiology. All Rights Reserved. ;Copyright © 2016, American Society for Microbiology. All Rights Reserved. 2016 American Society for Microbiology ;ISSN: 0022-538X ;EISSN: 1098-5514 ;DOI: 10.1128/jvi.00012-16 ;PMID: 27279612Full text available |
|
16 |
Material Type: Article
|
Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization modelNature communications, 2018-05, Vol.9 (1), p.1904-10, Article 1904 [Peer Reviewed Journal]2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2018 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-018-04216-6 ;PMID: 29765035Full text available |
|
17 |
Material Type: Article
|
Phase 1 Safety and Immunogenicity Study of a Respiratory Syncytial Virus Vaccine With an Adenovirus 26 Vector Encoding Prefusion F (Ad26.RSV.preF) in Adults Aged ≥60 YearsThe Journal of infectious diseases, 2020-08, Vol.222 (6), p.979-988 [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2020 ;The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jiaa193 ;PMID: 32320465Full text available |
|
18 |
Material Type: Article
|
Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in ChildrenThe Journal of infectious diseases, 2020-02, Vol.221 (4), p.534-543 [Peer Reviewed Journal]The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2019 ;The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jiz603 ;PMID: 31758177Full text available |
|
19 |
Material Type: Article
|
Impact and cost-effectiveness of strategies to prevent respiratory syncytial virus (RSV) disease in Vietnam: A modelling studyVaccine, 2023-11, Vol.41 (46), p.6782-6790 [Peer Reviewed Journal]2023 The Authors ;Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved. ;2023. The Authors ;2023 The Authors 2023 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2023.09.003 ;PMID: 37690873Full text available |
|
20 |
Material Type: Article
|
A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum AdjuvantThe Journal of infectious diseases, 2017-01, Vol.215 (1), p.24-33 [Peer Reviewed Journal]Copyright © 2017 Oxford University Press on behalf of the Infectious Diseases Society of America ;The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America 2016 ;The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jiw453 ;PMID: 27694633Full text available |